Journal: bioRxiv
Article Title: Mechanism of PMC (2,2,5,7,8-pentamethyl-6-chromanol), a sterically hindered phenol antioxidant, in rescuing oxidized low-density lipoprotein-induced cytotoxicity in human retinal pigment epithelial cells
doi: 10.1101/2025.06.19.660627
Figure Lengend Snippet: Continuous PMC presence is required for protection against ox-LDL. (A) Serum-starved hRPE cells were treated with either ox-LDL (200 µg/ml) and PMC (1.3 µM) alone or, ox-LDL and PMC under different treatment conditions. ox-LDL+PMC denotes simultaneous treatment, while in other treatment groups either the cells were pretreated with PMC or with ox-LDL. Following these treatments, media were replaced with ox-LDL+PMC, ox-LDL alone, or PMC alone. In another group, media were not replaced, and treatments were added to the same media. Cells were pretreated with PMC and ox-LDL was added to the same media or pretreated with ox-LDL and an approximately 10-fold higher PMC concentration (10 µM) was added to the same media. Untreated cells were considered as controls. Values are indicated as mean ± SEM of n=3. One-way ANOVA was used for statistical analysis, ***P<0.001. (B) Graphical summary of the PMC mediated protection against ox-LDL in RPE. Uptake of ox-LDL via the CD36 receptor causes lysosomal destabilization and oxidative stress in RPE leading to ROS generation. This triggers Nrf2 dissociation from Keap1 and its translocation to the nucleus where it interacts with the specific promoter region, ARE, leading to the upregulation of HMOX1 and NQO1. PMC prevents this upregulation of HMOX1/HO-1 and NQO1 levels by preventing ROS generation. Created using BioRender.
Article Snippet: Primary human fetal retinal pigmented epithelium cells (hRPE) (Lonza, USA) were cultured in 50% (v/v) DMEM/F12 (Life Technologies, USA)/50% (v/v) αMEM (Sigma-Aldrich, USA) supplemented with 1x penicillin-streptomycin, Glutamax, sodium pyruvate, non-essential amino acids (all from Life Technologies, USA).
Techniques: Concentration Assay, Translocation Assay